NIV Versus HFO for Acute Exacerbations of Interstitial Lung Diseases

NANot yet recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Interstitial Lung DiseaseAcute Respiratory Failure
Interventions
DEVICE

Noninvasive mechanical ventilation

Noninvasive mechanical ventilation is a respiratory technique which allows the administration of positive inspiratory and expiratory airway pressures in order to ventilate the lungs.

DEVICE

Nasal high-flow oxygen therapy

Nasal high-flow is a respiratory technique which allows the administration of warmed and humidified air, associated with oxygen.

DEVICE

Continuous positive airway pressure

Continuous positive airway pressure is a respiratory technique which allows to maintain a constant positive airway pressure during inspiration and expiration.

Trial Locations (1)

76000

ADIR Association, Rouen

All Listed Sponsors
lead

ADIR Association

OTHER

NCT06182956 - NIV Versus HFO for Acute Exacerbations of Interstitial Lung Diseases | Biotech Hunter | Biotech Hunter